| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K33199242 |
| PharmacoGx | BRD-K33199242 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MRGPRX4 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | RPL29 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.09 |
| mRNA | VEGFA | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | TSEN54 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |
| mRNA | GAS7 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.09 |
| mRNA | RP11-727F15.14 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | HCAR2 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | LYZ | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | PSMD4 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | TRAF3IP3 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.09 |
